Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Brain: the common site of relapse in patients with pancoast or superior sulcus tumors.

Shah H, Anker CJ, Bogart J, Graziano S, Shah CM.

J Thorac Oncol. 2006 Nov;1(9):1020-2.

2.

Outcome predictors for 143 patients with superior sulcus tumors treated by multidisciplinary approach at the University of Texas M. D. Anderson Cancer Center.

Komaki R, Roth JA, Walsh GL, Putnam JB, Vaporciyan A, Lee JS, Fossella FV, Chasen M, Delclos ME, Cox JD.

Int J Radiat Oncol Biol Phys. 2000 Sep 1;48(2):347-54.

PMID:
10974447
3.

Brain metastasis is an early manifestation of distant failure in stage III nonsmall cell lung cancer patients treated with radical chemoradiation therapy.

Germain F, Wai ES, Berthelet E, Truong PT, Lesperance M.

Am J Clin Oncol. 2008 Dec;31(6):561-6. doi: 10.1097/COC.0b013e318172d5f9.

PMID:
19060588
4.

[Outcome of surgical treatment for Pancoast lung carcinoma in Iceland].

Fridriksson BM, Jónsson S, Oskarsdottir GN, Orrason AW, Ísaksson HJ, Gudbjartsson T.

Laeknabladid. 2015 Jul;101(7-8):351-5. Icelandic.

PMID:
26158627
5.

Who may benefit from prophylactic cranial irradiation amongst stage III non-small cell lung cancer patients?

Alsan Cetin I, Akgun Z, Atasoy BM, Fulden Yumuk P, Abacioglu U.

J BUON. 2013 Apr-Jun;18(2):453-8.

PMID:
23818361
6.

Superior sulcus tumors: treatment selection and results for 85 patients without metastasis (Mo) at presentation.

Komaki R, Mountain CF, Holbert JM, Garden AS, Shallenberger R, Cox JD, Maor MH, Guinee VF, Samuels B.

Int J Radiat Oncol Biol Phys. 1990 Jul;19(1):31-6.

PMID:
2380092
7.

Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.

Kumar P, Herndon J 2nd, Langer M, Kohman LJ, Elias AD, Kass FC, Eaton WL, Seagren SL, Green MR, Sugarbaker DJ.

Cancer. 1996 Jun 1;77(11):2393-9.

8.

Results of combined modality treatment in patients with non-small-cell lung cancer of the superior sulcus and the rationale for surgical resection.

Kappers I, van Sandick JW, Burgers JA, Belderbos JS, Wouters MW, van Zandwijk N, Klomp HM.

Eur J Cardiothorac Surg. 2009 Oct;36(4):741-6. doi: 10.1016/j.ejcts.2009.04.069.

PMID:
19699647
9.

High risk of brain metastases in surgically staged IIIA non-small-cell lung cancer patients treated with surgery, chemotherapy, and radiation.

Mamon HJ, Yeap BY, Jänne PA, Reblando J, Shrager S, Jaklitsch MT, Mentzer S, Lukanich JM, Sugarbaker DJ, Baldini EH, Berman S, Skarin A, Bueno R.

J Clin Oncol. 2005 Mar 1;23(7):1530-7.

PMID:
15735128
11.

[Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].

Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.

Ai Zheng. 2006 Nov;25(11):1419-22. Chinese.

PMID:
17094913
12.

Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.

Sonett JR, Suntharalingam M, Edelman MJ, Patel AB, Gamliel Z, Doyle A, Hausner P, Krasna M.

Ann Thorac Surg. 2004 Oct;78(4):1200-5; discussion 1206. Review.

PMID:
15464470
13.

Lung cancer and its operable brain metastasis: survival rate and staging problems.

Furák J, Troján I, Szöke T, Agócs L, Csekeö A, Kas J, Svastics E, Eller J, Tiszlavicz L.

Ann Thorac Surg. 2005 Jan;79(1):241-7; discussion 241-7.

PMID:
15620950
14.

Survival of patients treated surgically for synchronous single-organ metastatic NSCLC and advanced pathologic TN stage.

Collaud S, Stahel R, Inci I, Hillinger S, Schneiter D, Kestenholz P, Weder W.

Lung Cancer. 2012 Dec;78(3):234-8. doi: 10.1016/j.lungcan.2012.09.011.

PMID:
23040415
15.

A nomogram to predict brain metastasis as the first relapse in curatively resected non-small cell lung cancer patients.

Won YW, Joo J, Yun T, Lee GK, Han JY, Kim HT, Lee JS, Kim MS, Lee JM, Lee HS, Zo JI, Kim S.

Lung Cancer. 2015 May;88(2):201-7. doi: 10.1016/j.lungcan.2015.02.006.

PMID:
25726044
16.

Aggressive therapy for patients with non-small cell lung carcinoma and synchronous brain-only oligometastatic disease is associated with long-term survival.

Gray PJ, Mak RH, Yeap BY, Cryer SK, Pinnell NE, Christianson LW, Sher DJ, Arvold ND, Baldini EH, Chen AB, Kozono DE, Swanson SJ, Jackman DM, Alexander BM.

Lung Cancer. 2014 Aug;85(2):239-44. doi: 10.1016/j.lungcan.2014.06.001.

17.

Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.

Collaud S, Waddell TK, Yasufuku K, Pierre AF, Darling GE, Cypel M, Rampersaud YR, Lewis SJ, Shepherd FA, Leighl NB, Cho J, Bezjak A, Tsao MS, Keshavjee S, de Perrot M.

J Thorac Oncol. 2013 Dec;8(12):1538-44. doi: 10.1097/01.JTO.0000437419.31348.a4.

18.

[Treatment outcome of locally advanced stage IIIA/B lung cancer].

Cicenas S, Zaliene A, Atkocius V.

Medicina (Kaunas). 2009;45(6):452-9. Lithuanian.

19.

Combined chest wall resection with vertebrectomy and spinal reconstruction for the treatment of Pancoast tumors.

York JE, Walsh GL, Lang FF, Putnam JB, McCutcheon IE, Swisher SG, Komaki R, Gokaslan ZL.

J Neurosurg. 1999 Jul;91(1 Suppl):74-80.

PMID:
10419372
20.

Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response.

Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, Molinari N, Reboul F.

Eur J Cardiothorac Surg. 2008 May;33(5):829-36. doi: 10.1016/j.ejcts.2008.01.063.

PMID:
18367406

Supplemental Content

Support Center